Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
What is This Site Help Center Crisis
Powered By

Top 5 search results for "Zydelig" in Resources. To see all results and access other features, sign up for free.

Posts
Resources
Q&A
People
Groups
Treatments
Oral Therapy vs. Traditional Chemotherapy for CLL/SLL
... Zydelig is taken in pill form twice a day. Some common side effects include diarrhea, tiredness, nausea, cough, and fever. Rare but serious side effects include liver problems, breathing problems, and infections. ...
Oral Therapy vs. Traditional Chemotherapy for CLL/SLL
... Zydelig is taken in pill form twice a day. Some common side effects include diarrhea, tiredness, nausea, cough, and fever. Rare but serious side effects include liver problems, breathing problems, and infections. ...
The Benefits of Targeted Therapy for Leukemia
... Idelalisib (Zydelig) and duvelisib (Copiktra) are PI3K inhibitors that may be recommended to treat this type of leukemia. Some people with acute myeloid leukemia (AML) have mutations in a gene called FLT3. Two types of kinase inhibitors can help treat people with this gene change — midostaurin (Rydapt) and gilteritinib (Xospata). ...
The Benefits of Targeted Therapy for Leukemia
... Idelalisib (Zydelig) and duvelisib (Copiktra) are PI3K inhibitors that may be recommended to treat this type of leukemia. Some people with acute myeloid leukemia (AML) have mutations in a gene called FLT3. Two types of kinase inhibitors can help treat people with this gene change — midostaurin (Rydapt) and gilteritinib (Xospata). ...
B-Cell Prolymphocytic Leukemia
... These targeted therapies include: Imbruvica (ibrutinib) Zydelig (idelalisib) Venclexta (venetoclax) If B-PLL is relapsed (came back after being treated) or refractory (resistant to treatment), doctors may recommend other treatment options. Stem Cell TransplantChemotherapy often damages healthy blood cells. ...
B-Cell Prolymphocytic Leukemia
... These targeted therapies include: Imbruvica (ibrutinib) Zydelig (idelalisib) Venclexta (venetoclax) If B-PLL is relapsed (came back after being treated) or refractory (resistant to treatment), doctors may recommend other treatment options. Stem Cell TransplantChemotherapy often damages healthy blood cells. ...
8 Leukemia Treatment Options You Should Know
... PI3K inhibitors include: Duvelisib (Copiktra) Idelalisib (Zydelig) FLT3 InhibitorsIn some cases of AML, cancer cells have a mutation (change) in a gene called FLT3. ...
8 Leukemia Treatment Options You Should Know
... PI3K inhibitors include: Duvelisib (Copiktra) Idelalisib (Zydelig) FLT3 InhibitorsIn some cases of AML, cancer cells have a mutation (change) in a gene called FLT3. ...
Chronic Lymphocytic Leukemia Treatment Options
... Targeted therapies used to treat CLL include: Bruton’s tyrosine kinase inhibitors, including Brukinsa (zanubrutinib), Calquence (acalabrutinib), and Imbruvica (ibrutinib) Phosphoinositide 3-kinase inhibitors, including Copiktra (duvelisib) and Zydelig (idelalisib) The B-cell lymphoma 2 inhibitor Venclexta (venetoclax) Monoclonal antibodies are another ...
Chronic Lymphocytic Leukemia Treatment Options
... Targeted therapies used to treat CLL include: Bruton’s tyrosine kinase inhibitors, including Brukinsa (zanubrutinib), Calquence (acalabrutinib), and Imbruvica (ibrutinib) Phosphoinositide 3-kinase inhibitors, including Copiktra (duvelisib) and Zydelig (idelalisib) The B-cell lymphoma 2 inhibitor Venclexta (venetoclax) Monoclonal antibodies are another ...